Identification of a novel metallo-β-lactamase VIM-28 located within unusual arrangement of class 1 integron structure in Pseudomonas aeruginosa isolates from Egypt

Japanese Journal of Infectious Diseases

Volumn 67, Issue 5, 2014, Pages 382-384

  El Mahdy, Taghrid S ^a  

^a HELWAN UNIVERSITY   (Egypt)

Author keywords

BlaVIM< inf>; Carbapenem resistance; Egypt; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; AZTREONAM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METALLO BETA LACTAMASE; METALLO BETA LACTAMASE VIM 28; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; UNCLASSIFIED DRUG; BETA LACTAMASE;

AMINO ACID SEQUENCE; ANTIBIOTIC SENSITIVITY; ARTICLE; EGYPT; ESCHERICHIA COLI; HUMAN; HYBRIDIZATION; INTEGRON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; QUALITY CONTROL; SEQUENCE ANALYSIS; SOUTHERN BLOTTING; DNA SEQUENCE; DRUG EFFECTS; ENZYMOLOGY; GENE ORDER; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR GENETICS; MOLECULAR TYPING; MULTIDRUG RESISTANCE; PSEUDOMONAS INFECTION;

BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EGYPT; ELECTROPHORESIS, GEL, PULSED-FIELD; GENE ORDER; HUMANS; INTEGRONS; MOLECULAR SEQUENCE DATA; MOLECULAR TYPING; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEQUENCE ANALYSIS, DNA;

EID: 84907275315     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.67.382     Document Type: Article

References (21)

1. Aloush V, Navon-Venezia S, Seigman-Igra Y, et al. Multidrugresistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob Agents Chemother. 2006; 50: 43-8.
2. Rossolini GM, Mantengoli E. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin Microbiol Infect. 2005; 11: 17-32.
3. Walsh TR, Toleman MA, Poirel L, et al. Metallo-b-lactamases: the quiet before the storm? Clin Microbiol Rev. 2005; 18: 306-25.
4. Lister PD, Wolter DJ, Hanson ND. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev. 2009; 22: 582-610.
5. Walther-Rasmussen J, Høiby N. Class A carbapenemases. J Antimicrob Chemother. 2007; 60: 470-82.
6. Cornaglia G, Giamarellou H, Rossolini GM. Metallo-b-lactamases: a last frontier for β-lactams? Lancet Infect Dis. 2011; 11: 381-93.
7. Mazzariol A, Mammina C, Koncan R, et al. A novel VIM-type metallo-b-lactamase (VIM-14) in a Pseudomonas aeruginosa clinical isolate from a neonatal intensive care unit. Clin Microbiol Infect. 2011; 17: 722-4.
8. El-Kholy A, Saied T, Gaber M, et al. Device-associated nosocomial infection rates in intensive care units at Cairo University hospitals: first step toward initiating surveillance programs in a resource-limited country. Am J Infect Control. 2012; 40: e216-20.
9. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 21st informational supplement, M100-S21. Wayne, PA: CLSI; 2011.
10. Goering RV. Pulsed-field gel electrophoresis. In: Persing DH, Tenover FC, Versalovic J, et al., editors. Molecular Microbiology: Diagnostic Principles and Practice. Washington DC: ASM Press; 2004. p. 185-95.
11. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995; 33: 2233-339.
12. Lee K, Chong Y, Shin HB, et al. Modified Hodge and EDTA-disk synergy tests to screen metallo-b-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect. 2001; 7: 88-91.
13. Bissonnette L, Roy PH. Characterization of In0 of Pseudomonas aeruginosa plasmid pVS1, an ancestor of integrons of multiresistance plasmids and transposons of gram-negative bacteria. J Bacteriol. 1992; 174: 1248-57.
14. Leá vesque C, Roy PH. PCR analysis of integrons. In: Persing DH, Smith TF, Tenover FC, et al., editors. Diagnostic Molecular Microbiology: Principles and Applications. Rochester, MN: Mayo Foundation; 1993. p. 590-4.
15. Merino M, Peá rez-Llarena FJ, Kerff F, et al. Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-b-lactamases. J Antimicrob Chemother. 2010; 65: 1950-4.
16. Sinnett D, Montpetit A. Isolation of cosmid and BAC DNA from E. coli. Methods Mol Biol. 2003; 235: 99-102.
17. Pitout JD, Thomson KS, Hanson ND, et al. Plasmid-mediated resistance to expanded-spectrum cephalosporins among Enterobacter aerogenes strains. Antimicrob Agents Chemother. 1998; 42: 596-600.
18. Szaboá D, Szentandraá ssy J, Juhaá sz Z, et al. Imported PER-1 producing Pseudomonas aeruginosa, PER-1 producing Acinetobacter baumanii and VIM-2-producing Pseudomonas aeruginosa strains in Hungary. Ann Clin Microbiol Antimicrob. 2008; 7: 12.
19. Marchiaro P, Viale AM, Ballerini V, et al. First report of a Tn402-like class 1 integron carrying blaVIM-2 in Pseudomonas putida from Argentina. J Infect Dev Ctries. 2010; 4: 412-6.
20. Santos C, Caetano T, Ferreira S, et al. Tn5090-like class 1 integron carrying blaVIM-2 in a Pseudomonas putida strain from Portugal. Clin Microbiol Infect. 2010; 16: 1555-67.
21. Dimude JU, Amyes SG. Molecular characterisation and diversity in Enterobacter cloacae from Edinburgh and Egypt carrying blaCTX-M-14 and blaVIM-4 β-lactamase genes. Int J Antimicrob Agents. 2013; 41: 574-7.